Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Hydrochlorothiazide
Obesity Disorder
University of Kansas Medical CenterP4BB (66)
Iduronidase, .Alpha.-L-(8-Histidine) (Human)
Mucopolysaccharidosis Type 1
University of California, San FranciscoP4BB (66)
Indocyanine Green
Vulva Cancer
Istanbul UniversityP4BB (66)
Ioflupane
Dementia
Mayo ClinicP4BB (66)
Ioflupane
REM Sleep Behavior Disorder
Weill Medical College of Cornell UniversityP4BB (66)
Irinotecan
Her2-Receptor Negative Breast Cancer
GI Innovation, Inc.P4BB (66)
Iron
Iron Deficiency Anemia
Cairo UniversityP4BB (66)
Iron(Ii) Sulphate (1:1), Heptahydrate
Anemia
Korea University Guro HospitalP4BB (66)
Isocyclophosphamide
Burkitt Lymphoma
Federal Research Institute of Pediatric Hematology, Oncology and ImmunologyP4BB (66)
Ivonescimab
Hepatocellular Carcinoma
AkesoP4BB (66)
Ketorolac
Breast Cancer
Cairo UniversityP4BB (66)
Lemborexant
Insomnia
YangPanP4BB (66)
Lenalidomide
Extranodal Nasal NK/T Cell Lymphoma
Xinhua Hospital, Shanghai Jiao Tong University School of MedicineP4BB (66)
Lenalidomide
Follicular Lymphoma
Sinocelltech Ltd.P4BB (66)
Lenvatinib
Kidney Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (66)
Letrozole
Breast Carcinoma In Situ
Alliance for Clinical Trials in OncologyP4BB (66)
Letrozole
Hormone Receptor-Positive Breast Cancer
Universitaire Ziekenhuizen KU LeuvenP4BB (66)
Letrozole
Female Infertility
Peking University Third HospitalP4BB (66)
Letrozole
Invasive Ductal Breast Carcinoma
University of WashingtonP4BB (66)
Letrozole
Pregnancy Disorder With Abortive Outcome
Dubai Fertility CenterP4BB (66)
Lidocaine
Obesity Disorder
IVO JURISICP4BB (66)
Lidocaine
Substance-Related Disorder
Tanta UniversityP4BB (66)
Liraglutide
Infertility Disorder
Peking University Third HospitalP4BB (66)
Liraglutide
Female Infertility
Mỹ Đức HospitalP4BB (66)
Lorazepam
Schizophrenia
Temple UniversityP4BB (66)
Showing 1976 to 2000 of 42,301 assets
PreviousPage 80 of 1693Next